Blog

Vikram M. Narayan: New findings on MRD detection in urinary DNA for NMIBC

Vikram M. Narayan/X

Oct 25, 2024, 16:11

Vikram M. Narayan: New findings on MRD detection in urinary DNA for NMIBC

Vikram M. Narayan, Urologic Cancer Surgeon at GradyHealth, shared a post on X:

“New findings on MRD detection in urinary DNA for BCG Unresponsive NMIBC!

Using Convergent Genomics UroAmp test, we:

• Prognosticate 12-mo RFS post Nadofaragene (Adstiladrin)
• Characterize utDNA changes over time.”

Vikram M. Narayan

Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec

Authors: Vikram M. Narayan, Come Tholomier, Sharada Mokkapati, Alberto Martini, Vincent M. Caruso, Mahdi Goudarzi, Brian C. Mazzarella, Kevin G. Phillips, Vincent T. Bicocca, Trevor G. Levin, Seppo Yla-Herttuala, David J. McConkey and Colin P.N. Dinney.

Vikram M. Narayan

Alberto Martini Brian C. Mazzarella cancer cancer awareness cancer care Colin P.N. Dinney Come Tholomier Convergent Genomics David J. McConkey fight against cancer Global fight against cancer Kevin G. Phillips Mahdi Goudarzi NMIBC OncoDaily Oncology Seppo Yla-Herttuala Sharada Mokkapati Trevor G. Levin Vikram M. Narayan Vincent M. Caruso Vincent T. Bicocca

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage